Press Releases

Tikva Allocell Secures $8 Million Series A Financing to Advance Engineered Off-the-Shelf Cell Therapies for Solid Tumors

Featured Press Release, Milestone, News, Press Releases, Uncategorized / By

SINGAPORE and UNITED STATES — 22 JULY 2026 — Tikva Allocell today announced the successful closing of an $8 million Series A financing round, led by Kantharos Capital. The capital will accelerate the development of Tikva’s novel off-the-shelf, engineered allogeneic T-cell platform designed to tackle persistent challenges in solid tumor oncology. The funding will primarily support …

Tikva Allocell Secures $8 Million Series A Financing to Advance Engineered Off-the-Shelf Cell Therapies for Solid Tumors Read More »

Tikva published paper on Novel OX40 and 4-1BB Derived Spacers Enhance CD30 CAR Activity and Safety in CD30 Positive Lymphoma Models

Leave a Comment / Featured Publications, News, Press Releases, Publications / By

SINGAPORE – 8 Jul 2024 – Tikva Allocell Scientists published scientific article in Cell Molecular Therapy on Novel OX40 and 4-1BB Derived Spacers Enhance CD30 CAR Activity and Safety in CD30 Positive Lymphoma Models. The chimeric antigen receptor is made up of several domain, all of which have important roles to play in determining the …

Tikva published paper on Novel OX40 and 4-1BB Derived Spacers Enhance CD30 CAR Activity and Safety in CD30 Positive Lymphoma Models Read More »

Tikva published paper on promising off-the-shelf CAR T cell therapy targeting B7-H3 positive solid tumors

Featured Publications, News, Press Releases, Publications / By

SINGAPORE – 28 May 2024 – Tikva Allocell scientists publish scientific article in Cancer Research Communications on a promising off-the-shelf CAR T cell therapy targeting B7-H3 positive solid tumors. Despite the significant advances of CAR T cell therapy in blood cancer treatment, its success in solid tumors remains limited. In this paper, we show that with …

Tikva published paper on promising off-the-shelf CAR T cell therapy targeting B7-H3 positive solid tumors Read More »